The Drug Information Association (DIA), a global, membership-driven association that serves more than 30,000 professionals who are involved in the lifecycle management of pharmaceuticals and medical products, will host its 44th Annual Meeting at the Boston Convention Center in Boston,
Dr. David B. Samadi, M.D. announces Trifecta Breakthrough, launching a new era in prostate cancer treatment and cure with quick recovery and minimal post operative complications (PRWeb Apr 23, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb885034.htm
Engineering Content Management specialist strengthens market position with ImandrA product suite (PRWeb Apr 23, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb882444.htm
Propelled by high demand from pharmaceutical and diagnostics markets, specialty enzymes market has been witnessing high growth rates. Global specialty enzymes market is projected to exceed $4.4 billion by the year 2012. (PRWeb Apr 23, 2008) Read the full story
SynCardia Systems, Inc., manufacturer of the CardioWest(TM) temporary Total Artificial Heart (TAH-t), has honored Mayo Clinic Arizona and Virginia Commonwealth University Medical Center as CardioWest 100% Centers for 2007. (PRWeb Apr 23, 2008) Read the full story at
The Web Marketing Association announces the call for entries for its 12th annual international WebAward Competition for Web site development at www.webaward08.org. The Web Marketing Association will once again name the Best Pharmaceutical Web site of 2008. (PRWeb Apr 23,
Sleeping pills are consumed in the tens of millions daily, with the chemical residue finding its way into to the water table and the packaging either land filled or recycled. There is an alternative and its called the GLO TO
Pfizer has announced that Lipitor 80mg reduced the risk of heart attack and stroke by 32% in patients who have heart disease and chronic kidney disease compared with patients taking the 10mg dose of Lipitor.
Sigma-Tau Pharmaceuticals, a US based, wholly owned subsidiary of the Sigma-Tau Group, has announced that the European Commission has granted an orphan drug designation for Artesunate for the treatment of malaria.
Mylan Pharmaceuticals has received final approval from the FDA for its abbreviated new drug application for felodipine extended-release tablets USP, 2.5mg, 5mg and 10mg, for the treatment of hypertension.
St Jude Medical has received a patent from the US Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25.
Gene Express has signed an agreement with the Division of Patents & Licensing Research Office at the University of South Florida to license some of their gene expression technology necessary to develop prognostic tests for cisplatin and irinotecan chemoresistance.
Pipex Pharmaceuticals has announced that the FDA has opened an investigational new drug application to conduct a double-blind, randomized, placebo-controlled Phase II clinical trial of oral flupirtine for the treatment of fibromyalgia, a rheumatic pain disease.
Illumina has introduced the HumanHT-12 BeadChip, a twelve sample product designed to accelerate whole genome expression and expression-based Quantitative Trait Loci studies.
Fresenius Kabi, a business segment of health care group Fresenius, has acquired 73.3 % of the share capital of the Indian company Dabur Pharma for a price of INR8,782 million or INR76.50 per share in cash.
Perrigo has filed an abbreviated new drug application for over-the-counter Miconazole Nitrate Vaginal Cream, 2% and Suppository, 1.2g, a generic version of Monistat 1 Combination Pack.
Actelion and Nippon Shinyaku have signed a license agreement on a novel orally available PGI2 receptor agonist NS-304 originally discovered and synthesized by Nippon Shinyaku for the treatment of pulmonary arterial hypertension.
